Abstract:Amyotrophic lateral sclerosis (ALS) is intensively associated with insoluble aggregates formed by transactivation response element DNA-binding protein 43 (TDP-43) in the cytoplasm of neuron cells. A recent experimental study reported that two ALS-linked familial variants, A315E and A315pT (pT, phosphorylated threonine), can induce irreversible aggregation of the TDP-43 312NFGAFS317 segment (TDP-43312-317). However, the underlying molecular mechanism remains largely elusive. Here, we investigated the early aggregation process of the wild type (WT) 312NFGAFS317 segment and its A315E and A315pT variants by performing multiple microsecond all-atom molecular dynamics simulations. Our simulations show that the two variants display lower fluidity than WT, consistent with their decreased labilities observed in previous denaturation assay experiments. Despite each of the two variants carrying one negative charge, unexpectedly, we find that both A315E mutation and A315pT phosphorylation enhance intermolecular interactions and result in the formation of more compact oligomers. Compared to WT, A315E oligomers possess low β-sheet content but a compact hydrophobic core, while A315pT oligomers have high β-sheet content and large β-sheets. Side chain hydrogen-bonding and hydrophobic interactions as well as N312-E315 salt bridges contribute most to the increased aggregation propensity of the A315E mutant. By contrast, main chain and side chain hydrogen-bonding interactions, side chain hydrophobic and aromatic interactions, are crucial to the enhanced aggregation capability of the A315pT variant. These results indicate that glutamate mutation and phosphorylation at position 315 induce the irreversible aggregation of TDP-43312-317 peptides through differential mechanisms, which remind us that we should be careful in the investigation of the phosphorylation effect on protein aggregation by using phosphomimetic substitutions. This study provides mechanistic insights into the A315E/A315pT-induced irreversible aggregation of TDP-43312-317, which may be helpful for the in-depth understanding of ALS-mutation/phosphorylation-associated liquid-to-solid phase transition of TDP-43 protein aggregates.

Phe-Gly motifs drive fibrillization of TDP-43’s prion-like domain condensates

Solid-State NMR Reveals the Structural Transformation of the TDP-43 Amyloidogenic Region upon Fibrillation

Cryo-EM structures of four polymorphic TDP-43 amyloid cores

TDP-43 Amyloid Fibril Formation via Phase Separation-Related and -Unrelated Pathways

Atomistic Insights into A315E Mutation-Enhanced Pathogenicity of TDP-43 Core Fibrils

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

ALS-associated A315E and A315pT Variants Exhibit Distinct Mechanisms in Inducing Irreversible Aggregation of TDP-43312-317 Peptides.

Intra-condensate demixing of TDP-43 inside stress granules generates pathological aggregates

Dissecting the Effect of ALS Mutation G335D on the Early Aggregation of the TDP-43 Amyloidogenic Core Peptide: Helix-to-β-Sheet Transition and Conformational Shift.

Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils

Structural details of helix-mediated TDP-43 C-terminal domain multimerization

Insights into the Aggregation Mechanism of RNA Recognition Motif Domains in TDP-43: a Theoretical Exploration

Structure of pathological TDP-43 filaments from ALS with FTLD

DNAJA2 and Hero11 mediate similar conformational extension and aggregation suppression of TDP-43

Hairpin trimer transition state of amyloid fibril

Metamorphism in TDP-43 prion-like domain determines chaperone recognition

Opto-controlled C9orf72 poly-PR forms anisotropic condensates causative of TDP-43 pathology in the nucleus

RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo

Insights into the Aggregation Mechanism of RRM Domains in TDP-43: A Molecular Dynamics Study

TDP43 and Huntingtin Exon-1 Undergo A Conformationally Specific Interaction That Strongly Alters the Fibril Formation of Both Proteins